Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and method of reducing TNFalpha levels
A Standard patent application filed on 28 May 1998 credited to Muller, George W.
;
Chen, Roger Shen-Chu
;
Stirling, David I.
Details
Application number :
77012
Application type :
Standard
Application status :
SEALED
Under opposition :
No
Proceeding type :
Invention title :
Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and method of reducing TNFalpha levels
Inventor :
Muller, George W.
;
Chen, Roger Shen-Chu
;
Stirling, David I.
Agent name :
Fisher Adams Kelly
Address for service :
GPO Box 1413 BRISBANE QLD 4001
Filing date :
28 May 1998
Associated companies :
Applicant name :
Celgene Corporation
Applicant address :
7 Powder Horn Drive Warren New Jersey 07059 United States Of America
Old name :
Celgene Corporation
;
Chen, Roger Shen-Chu
;
Muller, George W.
;
Stirling, David I.